UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000037811
Receipt No. R000043045
Scientific Title Effects of nutritional intervention for high risk patients of pressure ulcer
Date of disclosure of the study information 2019/08/30
Last modified on 2019/08/27 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of nutritional intervention for high risk patients of pressure ulcer
Acronym Effects of nutritional intervention for high risk patients of pressure ulcer
Scientific Title Effects of nutritional intervention for high risk patients of pressure ulcer
Scientific Title:Acronym Effects of nutritional intervention for high risk patients of pressure ulcer
Region
Japan

Condition
Condition high risk patients of pressure ulcer
Classification by specialty
Geriatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Examination of the influence on abdominal circumference and nutritional status by comparing the cases of 1200 Kcal / day and 900 Kcal / day
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes abdominal circumference
Key secondary outcomes risk assessment for pressure ulcer, body weight, bony prominences, skinfold thickness of iliac spine, TLC, T-chol, CRP, CRE, BUN, Alb, TP, Hb, fecal properties, frequency of defecation treatment, incidence of pressure ulcer

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking NO
Concealment

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Polymeric formula: 900 Kcal/day
Interventions/Control_2 Polymeric formula: 1200 Kcal/day
Interventions/Control_3 Oligomeric formula: 900 Kcal/day
Interventions/Control_4 Oligomeric formula: 1200 Kcal/day
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
60 years-old <=
Age-upper limit
99 years-old >
Gender Male and Female
Key inclusion criteria 1)Patients on OH scale: 5.5 or more
2)Patients on tube feeding, not oral intake
3)Patients on tube feeding, not oral intake
4)Patients on NG tube or PEG
5)Patients on 800-900 Kcal/day
6)Patients without pressure ulcer
7)Patients informed consent
8)Patients over 60 years old and under 99 years old
Key exclusion criteria 1)Patients with AST > 100 U/L or ALT > 100 U/L
2)Patients with HbA1c > 8.0 %
3)Patients with Cre > 2.0 mg/dL or BUN > 44 mg/dL
4)Patients with ASO
5)Patient who have an allergy to soy, gelatin, milk component
6)Patients treated with chemotherapy or radiotherapy
7)Patients with other conditions not suitable for this study
Target sample size 80

Research contact person
Name of lead principal investigator
1st name Takehiko
Middle name
Last name Ohura
Organization Pressure Ulcer & Wound Healing Research Center
Division name recearch center
Zip code 060-0063
Address 1-1, Minami 3-jo Nishi 2-chome Chuo-ku, Sapporo 060-0063 Japan
TEL 011-232-2208
Email t-ohura@mb.snowman.ne.jp

Public contact
Name of contact person
1st name Takehiko
Middle name
Last name Ohura
Organization Pressure Ulcer & Wound Healing Research Center
Division name recearch center
Zip code 060-0063
Address 1-1, Minami 3-jo Nishi 2-chome Chuo-ku, Sapporo 060-0063 Japan
TEL 011-232-2208
Homepage URL
Email t-ohura@mb.snowman.ne.jp

Sponsor
Institute Pressure Ulcer & Wound Healing Research Center
Institute
Department

Funding Source
Organization Otsuka Pharmaceutical Factory
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Sapporo Dermatology Clinic IRB
Address 1-1, Minami 3-jo Nishi 2-chome Chuo-ku, Sapporo 060-0063 Japan
Tel 011-221-8807
Email akira-ookawara@hokkaido.med.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 08 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2018 Year 07 Month 25 Day
Date of IRB
2018 Year 04 Month 24 Day
Anticipated trial start date
2018 Year 07 Month 26 Day
Last follow-up date
2020 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 08 Month 27 Day
Last modified on
2019 Year 08 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043045